Literature DB >> 23227793

Dendrobium moniliforme attenuates high-fat diet-induced renal damage in mice through the regulation of lipid-induced oxidative stress.

Woojung Lee1, Dae-Woon Eom, Yujung Jung, Noriko Yamabe, Seungyong Lee, Youngsic Jeon, Ye Ran Hwang, Ji Hwan Lee, Yong Kee Kim, Ki Sung Kang, Su-Nam Kim.   

Abstract

Obesity is an important and preventable risk factor for renal disease. The administration of an antioxidant with a lipid-lowering effect is an important therapeutic approach for kidney disease in obese patients. The present study was conducted to examine whether methanolic extract of Dendrobium moniliforme (DM), one of the most famous traditional medicines used in many parts of the world, has an antioxidant effect in vitro and an ameliorative effect on high-fat diet (HFD)-induced alterations such as renal dysfunction and lipid accumulation in vivo. The 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of DM extract (IC(50) = 29.6 μg/mL) was increased in a dose-dependent manner. The LLC-PK1 kidney cell damage induced by oxidative stress was significantly inhibited by the treatments with DM extract. In the animal study, DM extract (200 mg/kg) was orally administered every day for nine weeks to HFD-fed mice, and its effect was compared with that of metformin. The administration of DM extract decreased the elevated serum glucose, total cholesterol concentration and renal lipid accumulation in HFD-fed mice. It also ameliorated renal dysfunction biomarkers including serum creatinine and renal collagen IV deposition. Taken together, these results provide important evidence that DM extract exhibits a pleiotropic effect on obesity induced parameters and exerted a renoprotective effect in HFD-fed mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23227793     DOI: 10.1142/S0192415X12500905

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

1.  Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.

Authors:  Shiran Udi; Liad Hinden; Brian Earley; Adi Drori; Noa Reuveni; Rivka Hadar; Resat Cinar; Alina Nemirovski; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-08-31       Impact factor: 10.121

2.  Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

3.  Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR.

Authors:  Yun Zhao; Lu Peng; Li-Chao Yang; Xu-Dong Xu; Wei-Jie Li; Xiu-Mei Luo; Xin Jin
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

4.  Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway.

Authors:  Yaning Zheng; Lin Tang; Wenhan Huang; Ruyu Yan; Feifeng Ren; Lei Luo; Ling Zhang
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

5.  Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease.

Authors:  Shiran Udi; Liad Hinden; Majdoleen Ahmad; Adi Drori; Malliga R Iyer; Resat Cinar; Michal Herman-Edelstein; Joseph Tam
Journal:  Br J Pharmacol       Date:  2019-12-27       Impact factor: 8.739

Review 6.  Role of microRNAs in Obesity-Related Kidney Disease.

Authors:  Maite Caus; Àuria Eritja; Milica Bozic
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities.

Authors:  Anna Permyakova; Asaad Gammal; Liad Hinden; Michal Weitman; Marta Weinstock; Joseph Tam
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.